Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (3 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
1 selected
)
Type
Guidance (60)
Guidance programme
(
1 selected
)
Guidance programme
Clinical guidelines (1)
Diagnostics guidance (2)
Health technology evaluations (1)
Interventional procedures guidance (3)
NICE guidelines (1)
Technology appraisal guidance (60)
Apply filters
Showing 31 to 40 of 60
Sort by
Date
Title
Apply sorting
lung cancer
Remove lung cancer filter
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Dacomitinib for untreated EGFR mutation-positive non-small-cell
lung cancer
TA595
14 August 2019
14 August 2019
Atezolizumab in combination for treating metastatic non-squamous non-small-cell
lung cancer
TA584
5 June 2019
5 June 2019
Brigatinib for treating ALK-positive advanced non-small-cell
lung cancer
after crizotinib
TA571
20 March 2019
20 March 2019
Alectinib for untreated ALK-positive advanced non-small-cell
lung cancer
TA536
8 August 2018
8 August 2018
Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell
lung cancer
TA531
18 July 2018
18 July 2018
Crizotinib for treating ROS1-positive advanced non-small-cell
lung cancer
TA529
4 July 2018
4 July 2018
Atezolizumab for treating locally advanced or metastatic non-small-cell
lung cancer
after chemotherapy
TA520
16 May 2018
16 May 2018
Ceritinib for untreated ALK-positive non-small-cell
lung cancer
TA500
24 January 2018
24 January 2018
Pembrolizumab for treating PD-L1-positive non-small-cell
lung cancer
after chemotherapy
TA428
11 January 2017
12 September 2017
Pemetrexed for the maintenance treatment of non-small-cell
lung cancer
TA190
23 June 2010
10 August 2017
Previous page
1
2
3
Current page
4
5
6
Page
4
of
6
Next page
Results per page
10
25
50
All
Back to top